SEC Form 4 · accession 0001019056-19-000186
Aptevo Therapeutics Inc. · APVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marvin L White
Officer — President and CEO · Director
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 9:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001671584
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.52 | Feb 28, 2019 | A | 151,600 | A | — | Feb 28, 2029 | Common Stock | 151,600 | 151,600 | D |
Explanation of responses
- F1The options vest in three approximately equal annual installments beginning on February 28, 2020.